BOT - Always Surprising

 So here's why I like BOT. Theere's the good and the bad, so it's a nice balance.

First the bad. They screwed up with their FDA application for SB, their lead product. Yes, they were only minor mess-ups and easily fixed, but they simply should not have happened. The fix means about another 6-month wait before things explode.

And this is great news for investors who want to get in on the action. Why should they? Because I am expecting to double my money after those 6 monnths. And that's not a bad return. It beats the banks and it beats the market.

Now the good. Read the above and add this: The Board and Management team are all experienced and very knowledgeable (the mistake previously alluded to aside); There are more great products in the pipeline, and all they are waiting for is SB to get going to provide the capital for the next stage; and there is a strong possibility of a takeover by big pharma after the FDA approves SB (thishas been strongly recognised by the Board).

And this is great news for investors as a takeover might mean that (from here) the share price goes up 600% or more.

Of couorse, none of this is guaranteed, but it is looking awesome.

So the opportunities are there. Buying now means having the patience to sit back for 6 to 9 months to watch everything wash out. Buying in 30 days from now will inevitably mean you are spending more to get the same number of shares, except for 2 buying periods.

As another shareholder has said: shares should be well-priced just before Christmas as retail investors get out so that they can pay for the holidays, and also a month later when the credit card bill comes in.

So I like BOT because it is crammed full of opportunity and the upside is based on strength.

Remember, this is not financial advice and you should always do your own research. This is just me and why I am investing where I am.